/Zimmer%20Biomet%20Holdings%20Inc%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
Warsaw, Indiana-based Zimmer Biomet Holdings, Inc. (ZBH) operates as a medical technology company. It designs, manufactures, and markets orthopedic reconstructive products. With a market cap of $17.6 billion, Zimmer Biomet serves orthopedic surgeons, neurosurgeons, hospitals, healthcare dealers, and more.
The medical device manufacturer has significantly underperformed the broader market over the past year. ZBH stock prices have plunged 16.2% on a YTD basis and 19.2% over the past 52 weeks, compared to the S&P 500 Index’s ($SPX) 16.4% returns in 2025 and 14.1% gains over the past year.
